JP2009504712A5 - - Google Patents

Download PDF

Info

Publication number
JP2009504712A5
JP2009504712A5 JP2008526505A JP2008526505A JP2009504712A5 JP 2009504712 A5 JP2009504712 A5 JP 2009504712A5 JP 2008526505 A JP2008526505 A JP 2008526505A JP 2008526505 A JP2008526505 A JP 2008526505A JP 2009504712 A5 JP2009504712 A5 JP 2009504712A5
Authority
JP
Japan
Prior art keywords
group
alkyl
unbranched
cycloalkyl
branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008526505A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009504712A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/065418 external-priority patent/WO2007020286A2/en
Publication of JP2009504712A publication Critical patent/JP2009504712A/ja
Publication of JP2009504712A5 publication Critical patent/JP2009504712A5/ja
Withdrawn legal-status Critical Current

Links

JP2008526505A 2005-08-17 2006-08-17 カリウムチャンネル阻害化合物の使用方法 Withdrawn JP2009504712A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70894005P 2005-08-17 2005-08-17
PCT/EP2006/065418 WO2007020286A2 (en) 2005-08-17 2006-08-17 Method of using potassium channel inhibiting compounds

Publications (2)

Publication Number Publication Date
JP2009504712A JP2009504712A (ja) 2009-02-05
JP2009504712A5 true JP2009504712A5 (https=) 2009-09-03

Family

ID=37398383

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008526505A Withdrawn JP2009504712A (ja) 2005-08-17 2006-08-17 カリウムチャンネル阻害化合物の使用方法

Country Status (11)

Country Link
US (1) US20070191357A1 (https=)
EP (1) EP1928463A2 (https=)
JP (1) JP2009504712A (https=)
KR (1) KR20080039996A (https=)
CN (1) CN101232886A (https=)
AU (1) AU2006281368A1 (https=)
BR (1) BRPI0616995A2 (https=)
CA (1) CA2619480A1 (https=)
MX (1) MX2008002193A (https=)
RU (1) RU2008109911A (https=)
WO (1) WO2007020286A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1483283A4 (en) 2002-03-13 2007-04-11 Signum Biosciences Inc MODULATION OF PROTEIN METHYLATION AND PHOSPHOPROTEIN PHOSPHATE
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
CA2601777A1 (en) 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
AR062907A1 (es) 2006-09-22 2008-12-17 Solvay Pharm Bv Derivados de sulfonilpirazol y sulfonilpirazolincarboxamidina como antagonistas de 5-ht6
RU2358720C1 (ru) * 2008-04-15 2009-06-20 Замил Мустафа Кхалил М. Дауд Аль Способ лечения диабетической дистальной симметричной сенсомоторной полиневропатии нижних конечностей
AU2009239430B2 (en) 2008-04-21 2015-01-22 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
IN2014CN03333A (https=) * 2011-10-03 2015-07-03 Univ California
WO2013167997A2 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of metabolic syndrome
CN103393690B (zh) * 2013-08-01 2016-05-11 南通大学附属医院 Katp通道开放剂在制备治疗术后疼痛药物中的应用
TWI698438B (zh) 2015-03-13 2020-07-11 德商４Ｓｃ製藥公司 Ｋv１.３抑制劑及其醫學應用
TWI701249B (zh) 2015-03-13 2020-08-11 德商４Ｓｃ製藥公司 Ｋv１.３抑制劑及其醫學應用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3335A1 (fr) * 2000-03-23 2001-09-27 Solvay Pharm Bv Derives de 4,5-dihydro-1h-pyrazole ayant une activite antagoniste de cb1
KR100903760B1 (ko) * 2001-09-21 2009-06-19 솔베이 파마슈티칼스 비. 브이 Ｃｂ1-길항 작용을 가지는 신규한4,5-디하이드로-1ｈ-피라졸 유도체
IL157704A0 (en) * 2001-09-21 2004-03-28 Solvay Pharm Bv 4,5-dihydro-1h-pyrazole derivatives having potent cbi-antagonistic activity
TW200528102A (en) * 2003-10-24 2005-09-01 Solvay Pharm Gmbh Novel medical combination treatment of obesity involving 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
JP2008517976A (ja) * 2004-10-25 2008-05-29 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ１カンナビノイド受容体拮抗薬及びカリウムチャンネルオープナーから成る、真性糖尿病１型、肥満及び関連症状の治療用の医薬組成物

Similar Documents

Publication Publication Date Title
US6511997B1 (en) Aminopyrazole derivatives
KR102610573B1 (ko) 통풍 또는 고뇨산혈증과 관련된 증상의 치료 또는 예방을 위한 화합물, 조성물 및 방법
CA2674436A1 (en) Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors
PT1024138E (pt) Derivados de pirazole
JP2009504712A5 (https=)
CA2412968A1 (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors
JPWO2000039116A1 (ja) アミノピラゾール誘導体
JP2018502877A5 (https=)
KR100764330B1 (ko) 급성 및/또는 만성 신경학적 장애의 치료를 위한ｍＧｌｕＲ2 길항제 및 ＡＣｈＥ 억제제의 조합물
NZ595035A (en) Substituted diazole and triazole compounds and compositions and methods of use
TW200307535A (en) Therapeutic agent for cancer
WO2007056219A3 (en) [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
US8729073B2 (en) 5-methyl-1-(naphthalen-2-yl)-1H-pyrazole derivatives and their use in potentiating the effect of opioid analgesics
US20180334437A1 (en) Farnesoid x receptor antagonists
EP3108883A1 (en) Therapeutic uses of non-peptide inhibitors of the calcineurin - nfat signalling pathway
JP2017508795A5 (https=)
JP2017508794A5 (https=)
WO2008026125A3 (en) Anti cancer use of caffeic acid and derivatives
TN2009000452A1 (en) [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof
JP2016520128A5 (https=)
JP2007517007A5 (https=)
US20250361218A1 (en) Agents and methods for treating dysproliferative diseases
FI3827829T3 (fi) Ei-alkoholiperäisen rasvamaksan ehkäisyssä tai hoidossa käytettävä lääkekoostumus, joka sisältää vaikuttavana aineena gpr119-ligandin
JPWO2006022374A1 (ja) ２−フェニルピリジン誘導体
JP2011524362A5 (https=)